No blanket recommendation can be made for SGLT2 inhibitors and GLP-1 receptor agonists in adults with type 2 diabetes (T2D) ...

Adults with type 2 diabetes who initiate SGLT2 inhibitors within 3 months of a diagnosis of a urinary tract infection have a ...

Canagliflozin is generally well tolerated and improves blood sugar control in children and adolescents with type 2 diabetes, ...

Children and adolescents with type 2 diabetes had greater reductions in HbA1c with an oral SGLT2 inhibitor compared with ...

Germany: A retrospective cohort study has found that prior use of SGLT2 inhibitors in type 2 diabetes mellitus (T2DM) ...

There is lower risk for recurrent HF hospitalization in older patients that receive SGLT2is following acute decompensated heart failure.

A new observational study shows that sodium-glucose co-transporter 2 (SGLT2) inhibitors are associated with reduced risk of cardiovascular mortality, heart failure, and chronic kidney disease in ...

To be cost-effective first-line agents, the modeling showed that a price reduction of 70% for SGLT2 inhibitors and 90% for oral GLP1 receptor agonists would be needed based on a willingness-to-pay ...

With SGLT2 inhibitors, the first pill you swallow works — the response is measured in hours. The only adverse effect to discuss is risk for genital mycotic infections, which can be mitigated.

Conclusions: Intensification with an SGLT2 inhibitor on top of a DPP-4 inhibitor demonstrated slightly better efficacy and cost savings compared with switching to a GLP-1 RA in patients not at ...